|
Hi Everyone,
There is an interview in Medscape this morning with Dr. Edith Perez who was one of the PI's on one of the Herceptin trials. She states in that article that: "Our NCCTG N9831 trial enrolled patients with negative lymph nodes and tumors 1 cm or greater with estrogen receptor-negative disease and 2 cm or greater with estrogen receptor-positive disease. This eligibility criteria was somewhat arbitrary, so at this time, I would not limit the therapy based on tumor size. Anyone who has a HER2 positive breast cancer is a candidate for this therapy."
You can read the full article on Medscape. This latest information has importance for those of us who had HER2 +++ tumors under a centimeter with no nodal involvement and for whom our oncologists felt chemo was not warranted. I am revisiting this issue with my onc this week.
Blessings to all.
Petesmom
|
Threaded Mode